ANTIBODY FOR ADCC AND INDUCING CYTOKINE PRODUCTION
Details for Australian Patent Application No. 2003282160 (hide)
International Classifications
Event Publications
25 March 2004 Complete Application Filed
Priority application(s): 02/11416 13.09.02 FR; 03/07067 12.06.03 FR; 02/11415 13.09.02 FR
20 May 2004 Application Open to Public Inspection
Published as AU-A-2003282160
15 January 2009 Assignment before Grant
Laboratoire Francais Du Fractionnement et des Biotechnologies The application has been assigned to LFB Biotechnologies
16 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003282161-Cytokine production-inducing antibody
2003282159-CHIMERIC RECOMBINANT PROTEIN AND IN VITRO DIAGNOSIS
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser